Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens

By Ödmark I. S.   Bäckström T.   Jonsson B.   Bixo M.  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 92-102

Informa Healthcare

Access to resources Recommend Favorite

A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment

By Conner P.   Christow A.   Kersemaekers W.   Söderqvist G.   Skoog L.   Carlström K.   Tani E.   Mol-Arts M.   Schoultz B. von  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 50-58

Informa Healthcare

Access to resources Recommend Favorite

A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women

By Salobir B.G.u.   Keber I.   Vrabic L.  

Fertility and Sterility, Vol. 78, Iss. 6, 2002-12 ,pp. : 1178-1183

Elsevier

Access to resources Recommend Favorite

Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study

By Winkler U.H.   Altkemper R.   Kwee B.   Helmond F.A.   Coelingh Bennink H.J.T.  

Fertility and Sterility, Vol. 74, Iss. 1, 2000-07 ,pp. : 10-19

Elsevier

Access to resources Recommend Favorite

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study

By Nickelsen T.   Creatsas G.   Rechberger T.   Depypere H.   Erenus M.   Quail D.   Arndt T.   Bonnar J.  

Climacteric, Vol. 4, Iss. 4, 2001-12 ,pp. : 320-331

Informa Healthcare

Access to resources Recommend Favorite